In this context, it has been reported that miRNA-31 negatively regulates dystrophin gene expression, and interfering with its activity could help improve dystrophin recovery in Duchenne muscular dystrophy patients, increasing skeletal muscle regeneration [33]. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.